# Management of Etonogestrel Subdermal Implant-related Bleeding

> **NCT01658995** · PHASE3 · COMPLETED · sponsor: **Petra M. Casey** · enrollment: 82 (actual)

## Conditions studied

- ESI-related Bleeding

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01658995
- **Lead sponsor:** Petra M. Casey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-13
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658995, "Management of Etonogestrel Subdermal Implant-related Bleeding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01658995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*